Latest news
{{'2026-09-21T10:24:45Z' | dateFormatFilter}}
Novo's CagriSema delivers superior weight loss versus tirzepatide in REIMAGINE 5 trial
{{'2026-09-21T08:00:00Z' | dateFormatFilter}}
Highlights to be presented at Novo’s Capital Markets Day 2026
{{'2026-09-18T10:36:39Z' | dateFormatFilter}}
Novo’s once-weekly Sogroya® (somapacitan) receives positive CHMP opinion in Europe for children with idiopathic short stature (unexplained shortness)
Investors
Share price
{{priceData.date}} {{priceData.time}}
{{priceData.currentPrice}}
{{priceData.currency}}
Go to stock watch
{{priceData.change}} {{priceData.currency}}
